Interview with Philippe Baudier, Managing Director, S.M.B. Laboratories
Mr Baudier, what inspired you when you joined the company back in 1978 and what are your main goals today? Prior…
S.M.B. Laboratories
Last updated: 13.02.2014
Address: 26-28, rue de la Pastorale1080 – Brussels – Belgium
Tel: +32.2.411.48.28
Company description
S.M.B. is a Belgian based pharmaceutical company with global ambitions. Its objective is to become a leading European player in the field of oral and pulmonary drug delivery systems by being an innovative actor in the pharmaceutical industry.
Thanks to the success of its R&D Department, S.M.B. has become internationally recognized in the field of human health care in various high-tech areas such as Micropellets (microgranules for once daily administration), Lidose® (semi-solid lipidic matrix in hard capsule formulation), Divule® (high gloss gelatine coated tabs), DPI (Dry Powder Inhaler) and Effervescent Tablets design and large scale production.
Products and services
Together with its exclusive partners, S.M.B. Technology S.A. (Contract Manufacturing) and GALEPHAR M/F (Contract R&D), Laboratoires SMB’s activity embraces a large spectrum of competences in initial R&D, continuous R&D, Clinical Trials, Analytics, production, Regulatory Affairs and Marketing, supporting a pipeline of in-house formulations.
S.M.B. proposes a balanced portfolio of products mainly in:
Respiratory tract
Cardiovascular system
Pain management
OTC
Interviews
Related
Jacques Marbehant – Senior Vice President, Head of Global Manufacturing,…
Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…
Belgium / New ‘Corona Commissioner’ to Coordinate COVID-19 Response
The new Belgian government has moved to streamline its response to the COVID-19 crisis with the appointment of…
Jan de Backer – CEO, Fluidda
Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and…
Kristel de Bisschop – General Manager, Pierre Fabre Benelux
Pierre Fabre Benelux General Manager Kristel de Bisschop discusses the challenges and opportunities inherent in…
Kevin Houdenaert – General Manager, Recordati Benelux & Nordics
Kevin Houdenaert, general manager for Benelux and the Nordics at Italian rare disease, specialty and primary care…
The Long Read / Belgium: The Multifaceted
Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical…
Pharma Faces / Sonja Willems, Janssen Benelux
Belgium is a vitally important country for Johnson & Johnson’s pharmaceutical arm, Janssen, globally. In…
In Profile / Stéphane De Wit, A Pioneer in HIV Research
Belgian doctor, researcher and professor, Stéphane De Wit has been with the St Pierre University Hospital in…
Hospital Reform in Belgium / A Guarantee of Better Care?
Belgium’s healthcare system was ranked fourth in Europe in 2019, outperforming its peers across a number of…
Carl Laurent – Managing Director, Siemens Healthineers BeLux
Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain…
Axel De Muyt – General Manager & VP, Novo Nordisk Belgium
Axel De Muyt, general manager & VP of Novo Nordisk Belgium and Luxembourg, recounts his journey through the…
Cell & Gene Therapy Launches / Zolgensma® in Belgium: Lessons Learned
In late 2019 Novartis hit the headlines in Belgium after it refused to grant access to its one-off gene therapy…
